BlackRock Portfolio holdings
AUM
$5.23T
1-Year Return
24.48%
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
This Quarter Return
-3.24%
1 Year Return
+24.48%
3 Year Return
+103%
5 Year Return
+187.44%
10 Year Return
+430.33%
AUM
$3.7T
AUM Growth
-$213B
(-5.4%)
Cap. Flow
+$9.64B
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
20.61%
Holding
5,898
New
116
Increased
2,454
Reduced
2,619
Closed
128
Top Buys
| 1 |
S&P Global
SPGI
|
+$3.38B |
| 2 |
Advanced Micro Devices
AMD
|
+$3.36B |
| 3 |
Tesla
TSLA
|
+$2.58B |
| 4 |
Microsoft
MSFT
|
+$1.45B |
| 5 |
Amazon
AMZN
|
+$1.39B |
Top Sells
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$4.51B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$3.67B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.51B |
| 5 |
Exelon
EXC
|
+$1.36B |
Sector Composition
| 1 | Technology | 24.03% |
| 2 | Healthcare | 13.69% |
| 3 | Financials | 12.58% |
| 4 | Consumer Discretionary | 10.66% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
USAK
4126
DELISTED
USA Truck Inc
USAK
| $1.85M | ﹤0.01% |
90,006
+286
| +0.3% | +$5.89K |
|
4127
Redwire
RDW
$1.24B
| $1.85M | ﹤0.01% |
218,009
+2,383
| +1% | +$20.2K |
|
4128
Grupo Aval
AVAL
$4.04B
| $1.84M | ﹤0.01% |
403,469
-19,503
| -5% | -$88.7K |
|
4129
Schwab US Aggregate Bond ETF
SCHZ
$9B
| $1.83M | ﹤0.01% |
72,424
-4,506
| -6% | -$114K |
|
|
BKCC
4130
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $1.83M | ﹤0.01% |
434,568
-87,159
| -17% | -$367K |
|
4131
iShares JPMorgan EM Corporate Bond ETF
CEMB
$399M
| $1.83M | ﹤0.01% |
+39,398
| New | +$1.83M |
|
|
LJPC
4132
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.82M | ﹤0.01% |
426,513
-2,256
| -0.5% | -$9.64K |
|
4133
First United
FUNC
$237M
| $1.82M | ﹤0.01% |
80,654
+8,224
| +11% | +$185K |
|
4134
Aqua Metals
AQMS
$5.23M
| $1.81M | ﹤0.01% |
5,994
+21
| +0.4% | +$6.34K |
|
4135
Disc Medicine
IRON
$2.08B
| $1.81M | ﹤0.01% |
43,340
+1,461
| +3% | +$60.9K |
|
|
CANO.WS
4136
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
| $1.81M | ﹤0.01% |
1,143,694
-12,635
| -1% | -$20K |
|
4137
PLAYSTUDIOS Inc
MYPS
$120M
| $1.79M | ﹤0.01% |
369,565
+10,638
| +3% | +$51.6K |
|
4138
Ardmore Shipping
ASC
$504M
| $1.79M | ﹤0.01% |
398,318
+5,789
| +1% | +$26K |
|
4139
Beyond Air
XAIR
$12.6M
| $1.77M | ﹤0.01% |
13,245
+848
| +7% | +$113K |
|
4140
Lantronix
LTRX
$179M
| $1.77M | ﹤0.01% |
264,263
+10,568
| +4% | +$70.6K |
|
|
ZEPP
4141
Zepp Health
ZEPP
$716M
| $1.76M | ﹤0.01% |
153,104
+1,857
| +1% | +$21.4K |
|
4142
Star Group
SGU
$393M
| $1.76M | ﹤0.01% |
158,889
-3,449
| -2% | -$38.3K |
|
4143
Schwab International Equity ETF
SCHF
$51.2B
| $1.76M | ﹤0.01% |
95,724
+998
| +1% | +$18.3K |
|
4144
Stratus Properties
STRS
$158M
| $1.74M | ﹤0.01% |
40,368
+444
| +1% | +$19.1K |
|
4145
Schwab US Large- Cap ETF
SCHX
$60.3B
| $1.73M | ﹤0.01% |
96,333
+3,369
| +4% | +$60.5K |
|
|
AFIB
4146
DELISTED
Acutus Medical, Inc. Common Stock
AFIB
| $1.73M | ﹤0.01% |
1,243,674
-43,501
| -3% | -$60.5K |
|
|
ZYNE
4147
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.72M | ﹤0.01% |
838,459
+2,811
| +0.3% | +$5.76K |
|
4148
Transact Technologies
TACT
$46M
| $1.72M | ﹤0.01% |
243,461
+763
| +0.3% | +$5.38K |
|
4149
Horizon Technology Finance
HRZN
$294M
| $1.7M | ﹤0.01% |
122,134
-13,898
| -10% | -$193K |
|
|
IPHA
4150
Innate Pharma
IPHA
$184M
| $1.7M | ﹤0.01% |
504,408
+108,335
| +27% | +$364K |
|